Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
BI 764524 for Diabetic Retinopathy
Recruiting0 awardsPhase 2
Phoenix, Arizona
This trial is open to adults with moderate or high severity non-proliferative diabetic retinopathy. The purpose of the study is to see if a medicine called BI 764524 can help people
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service